Eli Lilly (LLY) Dividends payables (2009 - 2025)

Eli Lilly (LLY) has 17 years of Dividends payables data on file, last reported at $1.3 billion in Q2 2025.

• For the quarter ending Q2 2025, Dividends payables rose 14.93% year-over-year to $1.3 billion; the trailing twelve-month figure through Jun 2025 stood at $1.3 billion (up 14.93% YoY), and the FY2024 full-year result was $1.3 billion, up 15.15% from the prior year.
• Dividends payables for Q2 2025 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
• Across five years, Dividends payables topped out at $1.3 billion in Q4 2024 and bottomed at $770.8 million in Q2 2021.
• The 5-year median for Dividends payables is $1.0 billion (2022), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Dividends payables gained 14.45%; it then climbed 15.19% in 2023.
• A 5-year view of Dividends payables shows it stood at $885.5 million in 2021, then climbed by 14.87% to $1.0 billion in 2022, then gained by 14.94% to $1.2 billion in 2023, then rose by 15.15% to $1.3 billion in 2024, then fell by 0.08% to $1.3 billion in 2025.
• The last three Dividends payables figures came in at $1.3 billion (Q2 2025), $1.3 billion (Q4 2024), and $1.2 billion (Q2 2024), per Business Quant data.

Peer Comparison